Literature DB >> 23159130

Screening of cardiovascular autonomic neuropathy in patients with diabetes using non-invasive quick and simple assessment of sudomotor function.

C S Yajnik1, V Kantikar, A Pande, J-P Deslypere, J Dupin, J-H Calvet, B Bauduceau.   

Abstract

AIM: Cardiovascular autonomic neuropathy (CAN) is a common but often overlooked complication of diabetes. Sympathetic C-fibers innervating sweat glands can be impaired early on in patients with diabetes. In this study, SUDOSCAN, a new non-invasive device that assesses sudomotor function was compared to methods generally used for the investigation of CAN. PATIENTS: A total of 232 patients with diabetes were measured for heart rate variability (HRV) at rest and during moderate activity. Time and frequency domain analysis techniques, including measurement of the low-frequency (LF) domain component, were assessed during HRV testing. Ewing tests, as recommended by the French Health Authority, were also done. Electrochemical sweat conductance (ESC) was measured on the hands and feet, and a risk-score was calculated.
RESULTS: Using two abnormal Ewing tests as a reference for the area under the curve (AUC) of the receiver operating characteristics (ROC) curve for SUDOSCAN, the risk-score was 0.74, with a sensitivity of 92% and specificity of 49% for a risk-score cut-off value of 35%. For the ROC curve analysis using the LF power component during moderate activity at a threshold of 90 ms(2) (first quartile) as reference, the AUC was higher for the SUDOSCAN risk-score (0.77) compared with the standard Ewing tests [E:I ratio (0.62), 30:15 ratio (0.76) and blood pressure change on standing (0.55)]. Using a cut-off value of 35%, risk-score sensitivity and specificity were 88 and 54%, respectively.
CONCLUSION: SUDOSCAN, which allows quick quantitative assessment of sudomotor function, may be used for early screening of CAN in everyday clinical practice before resorting to the more sophisticated and specific, but ultimately more time-consuming, Ewing tests.
Copyright © 2012 Elsevier Masson SAS. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23159130     DOI: 10.1016/j.diabet.2012.09.004

Source DB:  PubMed          Journal:  Diabetes Metab        ISSN: 1262-3636            Impact factor:   6.041


  29 in total

1.  [Screening and prevention of diabetes].

Authors:  P E H Schwarz
Journal:  Internist (Berl)       Date:  2015-10       Impact factor: 0.743

2.  Sudomotor function testing by electrochemical skin conductance: does it really measure sudomotor function?

Authors:  Sharika Rajan; Marta Campagnolo; Brian Callaghan; Christopher H Gibbons
Journal:  Clin Auton Res       Date:  2018-06-28       Impact factor: 4.435

Review 3.  Diabetes and cardiac autonomic neuropathy: Clinical manifestations, cardiovascular consequences, diagnosis and treatment.

Authors:  Akif Serhat Balcıoğlu; Haldun Müderrisoğlu
Journal:  World J Diabetes       Date:  2015-02-15

Review 4.  Electrochemical skin conductance: a systematic review.

Authors:  Peter Novak
Journal:  Clin Auton Res       Date:  2017-09-26       Impact factor: 4.435

5.  Variability of electrochemical skin conductance for screening diabetes mellitus.

Authors:  Soochan Kim; Junghee Cho; Boncho Ku; Minho Jun; Gahye Kim; Horyong Yoo; Sangsoo Park; Jaeuk U Kim
Journal:  Biomed Eng Lett       Date:  2019-04-24

6.  Autonomic nervous system function in women with anorexia nervosa.

Authors:  Zoe M Jenkins; David J Castle; Nina Eikelis; Andrea Phillipou; Gavin W Lambert; Elisabeth A Lambert
Journal:  Clin Auton Res       Date:  2021-11-11       Impact factor: 4.435

7.  Cardiac autonomic neuropathy risk estimated by sudomotor function and arterial stiffness in Chinese subjects.

Authors:  Q Zeng; S-Y Dong; M-L Wang; F Wang; J-M Li; X-L Zhao
Journal:  J Hum Hypertens       Date:  2016-01-07       Impact factor: 3.012

8.  Relationships between electrochemical skin conductance and kidney disease in Type 2 diabetes.

Authors:  Barry I Freedman; Donald W Bowden; Susan Carrie Smith; Jianzhao Xu; Jasmin Divers
Journal:  J Diabetes Complications       Date:  2013-10-17       Impact factor: 2.852

9.  Better diagnostic accuracy of neuropathy in obesity: A new challenge for neurologists.

Authors:  Brian C Callaghan; Rong Xia; Evan Reynolds; Mousumi Banerjee; Charles Burant; Amy Rothberg; Rodica Pop-Busui; Emily Villegas-Umana; Eva L Feldman
Journal:  Clin Neurophysiol       Date:  2018-01-16       Impact factor: 3.708

Review 10.  The New Age of Sudomotor Function Testing: A Sensitive and Specific Biomarker for Diagnosis, Estimation of Severity, Monitoring Progression, and Regression in Response to Intervention.

Authors:  Aaron I Vinik; Marie-Laure Nevoret; Carolina Casellini
Journal:  Front Endocrinol (Lausanne)       Date:  2015-06-11       Impact factor: 5.555

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.